NDC Product Labeler Boehringer Ingelheim Pharma Gmbh And Co. Kg

Boehringer Ingelheim Pharma Gmbh And Co. Kg labeler's code is 12714. The labeler has 50 products that have an assigned National Drug Code.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Product Type Status
12714-011 Butylscopolamine BromidePowderBulk IngredientUNFINISHED
12714-023 Homatropine MethylbromidePowderBulk IngredientUNFINISHED
12714-036 Dabigatran EtexilatePowderBulk IngredientUNFINISHED
12714-049 Ipratropium BromidePowderBulk IngredientUNFINISHED
12714-080 Interferon-gamma1bSolutionDrug For Further ProcessingUNFINISHED
12714-081 AlteplaseSolutionBulk IngredientUNFINISHED
12714-082 AlteplasePowderDrug For Further ProcessingUNFINISHED
12714-083 AlteplasePowderDrug For Further ProcessingUNFINISHED
12714-084 Interferon Beta-1bPowderDrug For Further ProcessingUNFINISHED
12714-085 AlemtuzumabSolutionDrug For Further ProcessingUNFINISHED
12714-087 DurvalumabSolutionBulk IngredientUNFINISHED
12714-088 InfliximabSolutionBulk IngredientUNFINISHED
12714-089 AlemtuzumabSolutionBulk IngredientUNFINISHED
12714-090 PembrolizumabSolutionDrug For Further ProcessingUNFINISHED
12714-091 PembrolizumabLiquidDrug For Further ProcessingUNFINISHED
12714-104 TremelimumabSolutionBulk IngredientUNFINISHED
12714-128 ZongertinibTabletDrug For Further ProcessingUNFINISHED
12714-133 Nintedanib EsilatePowderBulk IngredientUNFINISHED
12714-153 LinagliptinPowderBulk IngredientUNFINISHED
12714-195 IdarucizumabLiquidBulk IngredientUNFINISHED
12714-196 IdarucizumabLiquidDrug For Further ProcessingUNFINISHED
12714-201 EmpagliflozinPowderBulk IngredientUNFINISHED
12714-210 AlemtuzumabSolutionDrug For Further ProcessingUNFINISHED
12714-211 AlemtuzumabSolutionBulk IngredientUNFINISHED
12714-212 TafasitamabSolutionBulk IngredientUNFINISHED
12714-213 AldesleukinPowderDrug For Further ProcessingUNFINISHED
12714-214 RituximabSolutionBulk IngredientUNFINISHED
12714-215 RisankizumbabLiquidBulk IngredientUNFINISHED
12714-216 RisankizumbabLiquidBulk IngredientUNFINISHED
12714-217 RisankizumbabSolutionDrug For Further ProcessingUNFINISHED
12714-219 TafasitamabPowderDrug For Further ProcessingUNFINISHED
12714-230 PalivizumabSolutionBulk IngredientUNFINISHED
12714-231 PalivizumabSolutionDrug For Further ProcessingUNFINISHED
12714-232 PalivizumabSolutionDrug For Further ProcessingUNFINISHED
12714-233 TenecteplaseSolutionBulk IngredientUNFINISHED
12714-234 TenecteplasePowder, For SolutionDrug For Further ProcessingUNFINISHED
12714-235 TrastuzumabSolutionBulk IngredientUNFINISHED
12714-236 TenecteplasePowder, For SolutionDrug For Further ProcessingUNFINISHED
12714-240 SpesolimabLiquidBulk IngredientUNFINISHED
12714-901 TipranavirPowderBulk IngredientUNFINISHED
12714-902 SynjardyTabletDrug For Further ProcessingUNFINISHED
12714-903 SynjardyTabletDrug For Further ProcessingUNFINISHED
12714-904 SynjardyTabletDrug For Further ProcessingUNFINISHED
12714-906 SynjardyTabletDrug For Further ProcessingUNFINISHED
12714-915 Tiotropium BromidePowderBulk IngredientUNFINISHED
12714-916 OlodaterolPowderBulk IngredientUNFINISHED
12714-920 JardiancePowderDrug For Further ProcessingUNFINISHED
12714-930 JardiancePowderDrug For Further ProcessingUNFINISHED
12714-931 TelmisartanTabletDrug For Further ProcessingUNFINISHED
12714-932 TelmisartanTabletDrug For Further ProcessingUNFINISHED